JoVE Journal
Medicine
Medicine
A subscription to JoVE is required to view this content.
You will only be able to see the first 20 seconds.
Summary September 10th, 2014
Cancer stem cells (CSCs) are implicated in tumor relapse due to chemoresistance. We have optimized a protocol for selection and expansion of CSCs from ovarian cancer cell lines. By treating cells with the chemotherapeutic cisplatin and culturing in a stem cell promoting media we enrich for non-adherent CSC cultures.
